Robert Bauer

676 total citations
19 papers, 514 citations indexed

About

Robert Bauer is a scholar working on Psychiatry and Mental health, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert Bauer has authored 19 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Psychiatry and Mental health, 7 papers in Physiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert Bauer's work include Dementia and Cognitive Impairment Research (8 papers), Alzheimer's disease research and treatments (6 papers) and Diabetes Treatment and Management (6 papers). Robert Bauer is often cited by papers focused on Dementia and Cognitive Impairment Research (8 papers), Alzheimer's disease research and treatments (6 papers) and Diabetes Treatment and Management (6 papers). Robert Bauer collaborates with scholars based in United States, Denmark and Spain. Robert Bauer's co-authors include Kewei Chen, Eric M. Reiman, Richard J. Caselli, Michael W. Weiner, Catherine Gibbons, John E. Blundell, Auttawut Roontiva, Kirsten Dahl, Søren T. Hoff and Napatkamon Ayutyanont and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Journal of Nuclear Medicine.

In The Last Decade

Robert Bauer

19 papers receiving 508 citations

Peers

Countries citing papers authored by Robert Bauer

Since Specialization

Citations

This map shows the geographic impact of Robert Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Bauer more than expected).

Fields of papers citing papers by Robert Bauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Bauer. The network helps show where Robert Bauer may publish in the future.

Co-authorship network of co-authors of Robert Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Bauer. A scholar is included among the top collaborators of Robert Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Bauer. Robert Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme 2022 ·Diabetes Obesity and Metabolism ·Vanita R. Aroda, Robert Bauer, Erik Christiansen, Martin Haluzı́k, Klaus Kallenbach, Eduard Montanya, Julio Rosenstock, Juris J. Meier	27
2	Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study 2022 ·Journal of Alzheimer s Disease ·Richard J. Caselli, Yinghua Chen, Kewei Chen, Robert Bauer, Dona E.C. Locke, Bryan K. Woodruff	3
3	Surrogate endpoint evaluation using data from one large global randomized controlled trial 2021 ·BMC Medical Informatics and Decision Making ·Milan S. Geybels, Benjamin Ole Wolthers, Frederik Flindt Kreiner, Søren Rasmussen, Robert Bauer	1
4	Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding 2021 ·Journal of Alzheimer s Disease ·Cynthia M. Stonnington, (unknown), Jianfeng Wu, Jie Zhang, Jie Shi, Robert Bauer, (unknown), Yi Su, Dona E.C. Locke, Eric M. Reiman, Richard J. Caselli, Kewei Chen, Yalin Wang	5
5	An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Ildiko Lingvay, Robert Bauer, (unknown), Jack Lawson, Richard E. Pratley	13
6	A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL 2020 ·Digestive and Liver Disease ·Philippe L. Pereira, Dirk Arnold, Thierry de Baère, Fernando Gómez, Thomas Helmberger, Roberto Iezzi, Geert Maleux, Hans Prenen, Bruno Sangro, Anders Nordlund, Bleranda Zeka, Robert Bauer, (unknown), Olivier Pellerin, Julien Taı̈eb	5
7	932-P: Efficacy and Safety of Oral Semaglutide by Baseline Age in the PIONEER Clinical Trial Program 2020 ·Diabetes ·Vanita R. Aroda, Robert Bauer, CHRISTIN L. HERTZ, Eduard Montanya, Rasmus Sørrig, Mark Warren, Bertrand Cariou	7
8	Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes 2020 ·Diabetes Obesity and Metabolism ·Catherine Gibbons, John E. Blundell, Søren T. Hoff, Kirsten Dahl, Robert Bauer, Tine A. Bækdal	86
9	927-P: Effect of Oral Semaglutide with or without Background SGLT2i in Patients with T2D: Subgroup Analysis of PIONEER 4 2020 ·Diabetes ·Richard E. Pratley, Robert Bauer, Silvio E. Inzucchi, Kamlesh Khunti, Eskil Kreiner, Peter Nørkjær Laursen, Juris J. Meier	3
10	Brain imaging measurements of fibrillar amyloid‐β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele 2019 ·Alzheimer s & Dementia ·Valentina Ghisays, Dhruman D. Goradia, Hillary Protas, Robert Bauer, (unknown), Pierre N. Tariot, Val J. Lowe, David S. Knopman, Ronald C. Petersen, Clifford R. Jack, Richard J. Caselli, Yi Su, Kewei Chen, Eric M. Reiman	21
11	Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET 2018 ·Journal of Alzheimer s Disease ·Cynthia M. Stonnington, Yinghua Chen, Cary R. Savage, Wendy Lee, Robert Bauer, (unknown), Pradeep Thiyyagura, Gene E. Alexander, Richard J. Caselli, Dona E.C. Locke, Eric M. Reiman, Kewei Chen	11
12	Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism 2017 ·Alzheimer s Research & Therapy ·Henrietta M. Nielsen, Kewei Chen, Wendy Lee, Yinghua Chen, Robert Bauer, Eric M. Reiman, Richard J. Caselli, Guojun Bu	37
13	Applying sparse coding to surface multivariate tensor-based morphometry to predict future cognitive decline 2016 ·PubMed ·Jie Zhang, Cynthia M. Stonnington, Qingyang Li, Jie Shi, Robert Bauer, Boris A. Gutman, Kewei Chen, Eric M. Reiman, Paul M. Thompson, Jieping Ye, Yalin Wang	25
14	Morphometric analysis of hippocampus and lateral ventricle reveals regional difference between cognitively stable and declining persons 2016 ·PubMed ·Wen Zhang, Jie Shi, Cynthia M. Stonnington, Robert Bauer, Boris A. Gutman, Kewei Chen, Paul M. Thompson, Eric M. Reiman, Richard J. Caselli, Yalin Wang	3
15	P3‐285: Patch‐Based Sparse Coding and Multivariate Surface Morphometry for Predicting Amnestic Mild Cognitive Impairment and Alzheimer’S Disease in Cognitively Unimpaired Individuals 2016 ·Alzheimer s & Dementia ·Jie Zhang, Yalin Wang, Qingyang Li, Jie Shi, Robert Bauer, Kewei Chen, Eric M. Reiman, Richard J. Caselli, Cynthia M. Stonnington	3
16	Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region 2015 ·Journal of Nuclear Medicine ·Kewei Chen, Auttawut Roontiva, Pradeep Thiyyagura, Wendy Lee, Xiaofen Liu, Napatkamon Ayutyanont, Hillary Protas, Ji Luo, Robert Bauer, Cole Reschke, Daniel Bandy, Robert A. Koeppe, Adam Fleisher, Richard J. Caselli, Susan Landau, William J. Jagust, Michael W. Weiner, Eric M. Reiman	113
17	Clinical and multimodal biomarker correlates of ADNI neuropathological findings 2013 ·Acta Neuropathologica Communications ·Jon B. Toledo, Nigel J. Cairns, Xiao Da, Kewei Chen, Deborah Carter, Adam Fleisher, Erin Householder, Napatkamon Ayutyanont, Auttawut Roontiva, Robert Bauer, (unknown), Leslie M. Shaw, Christos Davatzikos, Michael W. Weiner, Eric M. Reiman, John C. Morris, John Q. Trojanowski, (unknown)	136
18	DT‐01–06: Baseline FDG‐PET and volumetric MRI predicts Alzheimer's disease conversion from mild cognitive impairment: An ADNI study 2013 ·Alzheimer s & Dementia ·Kewei Chen, Cynthia M. Stonnington, Napatkamon Ayutyanont, Cole Reschke, (unknown), Hillary Protas, Xiaofen Liu, Auttawut Roontiva, (unknown), Robert Bauer, Wendy Lee, Robert A. Koeppe, William Jagust, Norman L. Foster, Michael W. Weiner, Adam Fleisher, Eric M. Reiman	4
19	Scopolamine’s effect on passive avoidance 1970 ·Psychonomic Science ·(unknown), (unknown), Robert Bauer	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact